Bradykinin response was significantly higher in the matched control group 1 than in patients with COPD (maximal dilatation 1,314% ± 191% vs 552% ± 103%; P = .005) (Fig 2A). This evidence concerns the gene KNG1 and chronic obstructive pulmonary disease.